Unlocking Value,
Achieving Access
Impactful market access and evidence strategies for rare disease therapeutics and innovative technologies.
About Alkemi
Alkemi delivers evidence and value communication strategies for innovative medicines and technologies.
Our health economics, outcomes research and market access expertise spans US and global markets. Whether the decision-maker is a payer, regulator, reimbursement agency, hospital c-suite or policymaker, Alkemi can develop an effective evidence communication strategy.
Alkemi is aligned to our client goals – increased healthcare access for patients, improved health outcomes and quantified value for all healthcare stakeholders.
Alkemi Strategies & Solutions
Assess
Landscape
Build
Strategies & Evidence
Communicate
Value
Compelling Value Demonstration for Patient Access
Assess
We identify measures of value and define product impact in clinical, humanistic, and economic terms.
- Value Story, Evidence & Comparators
- Payment & Access Policy (e.g. Reimbursement, HTA )
- Stakeholders (e.g. Advocacy, Guidelines)
- Learn More
Build
We design and execute studies to quantify disease burden, patient outcomes and economic value.
- Value Messages, Evidence & Access Roadmap
- Data Collection & Study Design (e.g. Clinical & HEOR)
- Economic Models
- Learn More
Communicate
We deliver robust data package for negotiations with regulators, payers and other market access decision makers.
- Payer Value Tools
- Publications
- Dossiers
- Learn More
Execution
A new client engaged Alkemi in advance of a product launch to develop the value narrative, provide input on data collection and recommend a detailed plan to generate evidence needed for global patient access negotiations.
At project completion the client contracted Alkemi to provide comprehensive HEOR program oversight and plan execution through launch.
Our Mission
Alkemi unlocks value by providing expertise strategy leadership
to enable access to healthcare innovation.
